Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | 1,240,909 | reported | 02 Jan 2026 | tx 53+4,169,209−4,612,404 |
| Merck & Co., Inc. | 58,207 | reported | 05 May 2026 | tx 39+591,176−77,460 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | GRANT_AWARD | Merck & Co., Inc. | 19,885 | 0.00 USD | deriv |
| 05 May 2026 | GRANT_AWARD | Merck & Co., Inc. | 58,207 | 0.00 USD | deriv |
| 10 Feb 2026 | SALE | Merck & Co., Inc. | 10,235 | 117.52 USD | |
| 04 Feb 2026 | EXERCISE | Merck & Co., Inc. | 15,087 | 56.04 USD | |
| 04 Feb 2026 | SALE | Merck & Co., Inc. | 15,087 | 118.77 USD | |
| 04 Feb 2026 | EXERCISE | Merck & Co., Inc. | 15,087 | 0.00 USD | deriv |
| 26 Jan 2026 | GRANT_AWARD | Merck & Co., Inc. | 20,469 | 107.40 USD | |
| 02 Jan 2026 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 2,381 | 0.00 USD | |
| 01 Oct 2025 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 1,961 | 0.00 USD | |
| 01 Jul 2025 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 1,949 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 22,016 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 44,031 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Merck & Co., Inc. | 14,166 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Merck & Co., Inc. | 64,481 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 2,268 | 0.00 USD | |
| 27 Jan 2025 | GRANT_AWARD | Merck & Co., Inc. | 32,621 | 97.94 USD | |
| 02 Jan 2025 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 1,647 | 0.00 USD | |
| 01 Oct 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 1,925 | 0.00 USD | |
| 01 Jul 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 1,592 | 0.00 USD | |
| 03 Jun 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 13,097 | 0.00 USD | |
| 03 Jun 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 26,193 | 0.00 USD | deriv |
| 30 Apr 2024 | GRANT_AWARD | Merck & Co., Inc. | 65,625 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 1,267 | 0.00 USD | |
| 09 Feb 2024 | EXERCISE | Merck & Co., Inc. | 14,702 | 62.07 USD | |
| 09 Feb 2024 | SALE | Merck & Co., Inc. | 14,702 | 125.50 USD |